NYSEMKT:DXR
Daxor Corp Stock News
$9.65
+0 (+0%)
At Close: Apr 26, 2024
Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference
12:00pm, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
Oak Ridge, TN, March 23, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces that President and CEO Michael Feldschuh will p
Daxor reports FY results (NASDAQ:DXR)
02:15pm, Tuesday, 01'st Mar 2022 Seeking Alpha
Daxor press release (DXR): FY NAV of $5.24 per share versus $3.89 in FY 2020.
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Assessment of Heart Failure
01:00pm, Thursday, 17'th Feb 2022 GlobeNewswire
Daxor ’s BVA-100 ® Shown to Provide Unique and Actionable Data for Addressing Heart Failure
Daxor Corporation Commences Trading on The NASDAQ Capital Market
01:00pm, Wednesday, 02'nd Feb 2022 GlobeNewswire Inc.
Management to Ring the Nasdaq Stock Market Opening Bell on February 4, 2022
Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors
01:00pm, Friday, 21'st Jan 2022 GlobeNewswire Inc.
Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announced today that it has appointed Caleb DesRosiers, JD,
Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022
09:05pm, Thursday, 20'th Jan 2022 GlobeNewswire Inc.
Oak Ridge, TN, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
01:00pm, Thursday, 06'th Jan 2022 GlobeNewswire Inc.
Oak Ridge, TN, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh wil
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
08:00am, Thursday, 06'th Jan 2022
Oak Ridge, TN, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will
DAXOR AWARDED NEW PATENT FOR BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES
01:00pm, Tuesday, 04'th Jan 2022 GlobeNewswire Inc.
Method Patent Covers Blood Volume Analysis Technology to Evaluate and Guide Treatment Decisions in Multiple Medical Conditions
Daxor Corporation Receives $200K Matching Fund Award from Launch Tennessee
08:30am, Friday, 01'st Oct 2021
The SBIR/STTR Matching Fund Grant Will Advance the Company's Innovation and Commercialization Efforts, and Job Creation
Data from Three New Studies and Two Ongoing Trials Presented at the Heart Failure Society of America Annual Scientific Meeting 2021 Data Highlight Importance of Blood Volume Analysis in Providing Appr
Daxor Corporation to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
08:30am, Tuesday, 07'th Sep 2021
Oak Ridge, TN, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Daxor Corpor a tion (NYSE:DXR), the global leader in blood volume measurement technology, today announces that President and Chief Executive Officer M
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
08:30am, Wednesday, 01'st Sep 2021
Oak Ridge, TN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today it issued a corporate update in a Letter to S
Company forecasts further increase in sales driven by new distributor agreements
Data Led to Multi-Center Study In Progress At Three Leading Hospitals
